Kiadis Pharma Participates In Haploidentical Transplantation 2013 Forum
12/5/2013 6:22:55 AM
AMSTERDAM, December 5, 2013 /PRNewswire/ --
~ Prior to the American Society of Hematology Annual Meeting ~
Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, today announces that its lead product inventor, Denis-Claude Roy, MD, Professor of Medicine at the University of Montreal, is providing the following presentation: "Donor lymphocytes selectively photodepleted of alloreactive T cells can fight infections without causing GVHD" at the Haploidentical Transplantation 2013 forum in Metairie/New Orleans on December 5, 2013 prior to the annual meeting of the American Society of Hematology (ASH).
Help employers find you! Check out all the jobs and post your resume.
comments powered by